Pharmacokinetic Food-effect Study of Abiraterone Acetate (A.A) in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Phase of Trial: Phase I
Latest Information Update: 08 May 2019
Price : $35 *
At a glance
- Drugs Abiraterone acetate (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Pharmacokinetics
- Acronyms Abifood01
- 03 May 2019 Planned End Date changed from 1 Jun 2018 to 1 Mar 2020.
- 03 May 2019 Planned primary completion date changed from 1 Apr 2018 to 1 Dec 2019.
- 31 Aug 2018 Biomarkers information updated